- Home
- PLSE vs ADEA Comparison
PLSE vs ADEA Comparison
Compare PLSE & ADEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLSE
- ADEA
- Stock Information
- Founded
- PLSE 2014
- ADEA 1990
- Country
- PLSE United States
- ADEA United States
- Employees
- PLSE N/A
- ADEA N/A
- Industry
- PLSE Medical/Dental Instruments
- ADEA Computer Software: Prepackaged Software
- Sector
- PLSE Health Care
- ADEA Technology
- Exchange
- PLSE Nasdaq
- ADEA Nasdaq
- Market Cap
- PLSE 1.3B
- ADEA 1.3B
- IPO Year
- PLSE 2016
- ADEA N/A
- Fundamental
- Price
- PLSE $17.07
- ADEA $13.34
- Analyst Decision
- PLSE
- ADEA Strong Buy
- Analyst Count
- PLSE 0
- ADEA 3
- Target Price
- PLSE N/A
- ADEA $17.33
- AVG Volume (30 Days)
- PLSE 159.2K
- ADEA 502.0K
- Earning Date
- PLSE 05-08-2025
- ADEA 05-05-2025
- Dividend Yield
- PLSE N/A
- ADEA 1.51%
- EPS Growth
- PLSE N/A
- ADEA 89.09
- EPS
- PLSE N/A
- ADEA 0.66
- Revenue
- PLSE N/A
- ADEA $380,289,000.00
- Revenue This Year
- PLSE N/A
- ADEA $10.83
- Revenue Next Year
- PLSE N/A
- ADEA $3.41
- P/E Ratio
- PLSE N/A
- ADEA $20.12
- Revenue Growth
- PLSE N/A
- ADEA 7.16
- 52 Week Low
- PLSE $6.66
- ADEA $9.68
- 52 Week High
- PLSE $25.00
- ADEA $17.46
- Technical
- Relative Strength Index (RSI)
- PLSE 50.34
- ADEA 58.81
- Support Level
- PLSE $15.92
- ADEA $12.17
- Resistance Level
- PLSE $17.54
- ADEA $13.68
- Average True Range (ATR)
- PLSE 0.93
- ADEA 0.41
- MACD
- PLSE -0.08
- ADEA 0.21
- Stochastic Oscillator
- PLSE 32.58
- ADEA 82.64
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
About ADEA Adeia Inc.
Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property (IP) Licensing. In the IP segment, it primarily license innovations to leading companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.